KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals, Inc.（KALV）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
kalv · 股价预测 · 13 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 13 位华尔街分析师
Buy
13 位分析师
共识
评级分布
12 个月目标价
High
$32.00
Consensus
$28.67
+6.3% upside
Low
$27.00
Median: $27 · Last Close: $26.98
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$28.67
6.3% upside
High Target
$32
18.6%
Low Target
$27
0.1%
Current Price
$26.98
as of today
Based on analyst price targets, the KALV stock price prediction for the next 12 months ranges from $27 to $32. The consensus KALV price forecast of $28.67 implies 6.3% upside from the current price of $26.98.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $27.01 | ↑ 0.14% |
1-day model range: $26.66–$27.37. Peak: $27.37 (+0.14%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $28 | +5.0% |
| 2028 | $29 | +7.9% |
| 2029 | $30 | +9.5% |
| 2030 | $30 | +10.4% |
| 2031 | — | +10.9% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · KALV · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-01 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2026-04-30 | Needham | Downgrade ↓ | Buy→Hold |
| 2026-03-26 | Stifel | Maintains | Buy→Buy |
| 2026-03-26 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-03-25 | Needham | Maintains | Buy→Buy |
| 2026-01-09 | Needham | Maintains | Buy→Buy |
| 2026-01-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-01-06 | Needham | Maintains | Buy→Buy |
| 2025-12-04 | Needham | Maintains | Buy→Buy |
| 2025-11-11 | Citizens | Maintains | Market Outperform→Market Outperform |
Wall Street analysts have recently issued updated ratings on KalVista Pharmaceuticals, Inc. (KALV) stock. Of the recent 60 rating actions, 0 were upgrades and 2 were downgrades. 13 analysts currently cover KALV.
分析师推荐趋势
KALV analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$199M
↓ 53.2% YoY
Revenue Next Year
$311M
↑ 56.2% YoY
EPS This Year
$-1.21
EPS Next Year
$0.64
↓ 152.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast KALV EPS of $-1.21 for the current fiscal year, based on estimates from 3 analysts. The KALV revenue forecast is $199M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
KALV 股价预测由两类独立数据源支撑：来自 13 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。KALV 的共识目标价为 $28.67（+6.3% 上行空间），分析师共识为 Buy。
KALV 的短期预测（明日）为 $27.01（+0.14%）。 KALV 对 2027 年的股价预测均值为 $28。 KALV 对 2030 年的预测区间为 $26–$34。
KalVista Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 KALV。KALV 在 2027 年的整体展望偏积极，在覆盖分析师中约 85% 对应 Buy 共识。
常见问题
KALV 预测 · 8 个问题根据 13 位华尔街分析师，KALV 的 12 个月平均目标价为 $28.67，最高 $32.00、最低 $27.00。若有图表，中位目标价可在上方查看。相对当前价 $26.98，隐含约 +6.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.